BioCentury
ARTICLE | Financial News

Aimmune Therapeutics amends IPO

August 3, 2015 7:00 AM UTC

Aimmune Therapeutics Inc., Brisbane, Calif. Business: Inflammation Date announced: 2015-07-27 Type: IPO To be raised: Up to $133.3 million Shares: 8.3 million Price: $14-$16 Underwriters: BofA Merrill...